stoxline Quote Chart Rank Option Currency Glossary
  
Danaher Corporation (DHR)
239.39  -0.95 (-0.4%)    04-17 16:00
Open: 240.42
High: 240.83
Volume: 2,456,829
  
Pre. Close: 240.34
Low: 238.165
Market Cap: 177,279(M)
Technical analysis
2024-04-17 4:21:19 PM
Short term     
Mid term     
Targets 6-month :  291.35 1-year :  299.6
Resists First :  249.44 Second :  256.51
Pivot price 244.39
Supports First :  238.02 Second :  198.03
MAs MA(5) :  240.66 MA(20) :  246.14
MA(100) :  238.99 MA(250) :  223.85
MACD MACD :  -2.6 Signal :  -1.7
%K %D K(14,3) :  12.1 D(3) :  10.8
RSI RSI(14): 37.7
52-week High :  259 Low :  182.08
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ DHR ] has closed above bottom band by 14.1%. Bollinger Bands are 14.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 241.52 - 242.86 242.86 - 243.95
Low: 233.82 - 235.74 235.74 - 237.31
Close: 236.57 - 239.41 239.41 - 241.73
Company Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Headline News

Wed, 17 Apr 2024
Danaher (NYSE:DHR) Upgraded to Buy by HSBC - MarketBeat

Wed, 17 Apr 2024
Mirova US LLC Has $273.42 Million Stake in Danaher Co. (NYSE:DHR) - MarketBeat

Wed, 17 Apr 2024
Danaher Corp (DHR) Upgraded to Buy from Hold - InvestorsObserver

Wed, 17 Apr 2024
The Art of Valuation: Discovering Danaher Corp's Intrinsic Value - GuruFocus.com

Wed, 17 Apr 2024
Danaher (NYSE:DHR) and OncoCyte (NASDAQ:OCX) Financial Survey - Defense World

Tue, 16 Apr 2024
Danaher (DHR) to Release Quarterly Earnings on Tuesday - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 741 (M)
Shares Float 659 (M)
Held by Insiders 10.7 (%)
Held by Institutions 81.6 (%)
Shares Short 6,350 (K)
Shares Short P.Month 6,070 (K)
Stock Financials
EPS 5.63
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 72.36
Profit Margin 19.9 %
Operating Margin 20.8 %
Return on Assets (ttm) 3.9 %
Return on Equity (ttm) 8.1 %
Qtrly Rev. Growth -23.5 %
Gross Profit (p.s.) 0
Sales Per Share 32.26
EBITDA (p.s.) 10.19
Qtrly Earnings Growth -51.3 %
Operating Cash Flow 7,160 (M)
Levered Free Cash Flow 4,860 (M)
Stock Valuations
PE Ratio 42.44
PEG Ratio 4.6
Price to Book value 3.3
Price to Sales 7.42
Price to Cash Flow 24.75
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android